This volume will describe both growth-inhibitory and mucin-depleting effects of bromelain and
N-acetylcysteine on their own or in combination in cancer. It will coherently review the
pathophysiological aspects of the mucin glycoproteins in malignancies and provide an updated
account of the status of bromelain and N-acetylcysteine in cancer therapy. The volume will
develop the idea of using these two drugs as a combination formulation for mucin-depleting
effects.
